NIAID, NIH, Bethesda, MD 20817, USA.
Trends Immunol. 2010 Mar;31(3):120-30. doi: 10.1016/j.it.2009.12.003. Epub 2010 Jan 19.
CD8(+) cytotoxic T lymphocyte (CTL) responses are crucial in establishing the control of persistent virus infections. Population studies of HIV-1-infected individuals suggest that CD8(+) CTL responses targeting epitopes that take the greatest toll on virus replication are instrumental in immune control. A major question for vaccine design is whether incorporating epitopes responsible for controlling a persistent virus will translate into protection from natural infection or serve solely as a fail-safe mechanism to prevent overt disease in infected individuals. Here, we discuss qualitative parameters of the CD8(+) CTL response and mechanisms operative in the control of persistent virus infections and suggest new strategies for design and delivery of HIV vaccines.
CD8(+) 细胞毒性 T 淋巴细胞 (CTL) 应答对于控制持续性病毒感染至关重要。对 HIV-1 感染者的群体研究表明,针对对病毒复制造成最大损害的表位的 CD8(+)CTL 应答对于免疫控制至关重要。疫苗设计的一个主要问题是,包含负责控制持续性病毒的表位是否会转化为对自然感染的保护,或者仅仅是作为感染个体预防显性疾病的失效安全机制。在这里,我们讨论了控制持续性病毒感染的 CD8(+)CTL 应答的定性参数和作用机制,并提出了设计和提供 HIV 疫苗的新策略。